Side-by-Side Comparison
PFE vs MRK
Big pharma. Compare price, valuation, growth, profitability, and balance-sheet quality — all in one view.
PFE wins 6·MRK wins 6·Updated daily
PFE
Pfizer, Inc.
Healthcare
$25.96
+34.79%
MRK
Merck & Company, Inc.
Healthcare
$113.45
+96.11%
Metric
PFE
MRK
Price
Last traded price
$25.96
$113.45
Day Change
Latest session move
+34.79%
+96.11%
Market Cap
Total equity value
$147.96B
$280.2B
P/E (TTM)
Trailing earnings multiple
19.8
32
Forward P/E
Forward earnings multiple
9.1
11.9
P/S
Price-to-sales ratio
2.34
4.26
EV/EBITDA
Enterprise value to EBITDA
7.8
10.9
Revenue (TTM)
Trailing twelve-month revenue
$63.32B
$65.77B
Revenue Growth
Year-over-year revenue growth
540.0%
490.0%
Profit Margin
Net income as % of revenue
1183.1%
1358.6%
Operating Margin
Operating income as % of revenue
3161.7%
3860.4%
Return on Equity
Net income as % of equity
831.0%
1894.4%
Debt / Equity
Total debt vs equity
71.6
106.94
Free Cash Flow
Trailing FCF
$12.38B
$14.05B
Dividend Yield
Annualized yield
100.00%
100.00%
Beta
Volatility vs market
0.31
0.2
52W High
12-month high
$28.75
$125.14
52W Low
12-month low
$21.97
$73.31
Highlighted values indicate the better reading for that metric, where direction is unambiguous. Lower is generally better for valuation multiples and leverage; higher is better for growth, margin, and cash-flow metrics. Educational data only, not investment advice.
Go deeper than a side-by-side.
Add PFE and MRK to your Meridian watchlist for live alerts, AI-driven setups, and full earnings coverage.